US Patent Issued to Ventana Medical Systems on May 19 for "Polynucleotides encoding anti-PD-L1 antibodies" (California, Arizona Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,635, issued on May 19, was assigned to Ventana Medical Systems Inc. (Tucson, Ariz.).

"Polynucleotides encoding anti-PD-L1 antibodies" was invented by Marcin Kowanetz (San Francisco), Hartmut Koeppen (San Mateo, Calif.), Zachary Boyd (Oakland, Calif.), Zhiming Liao (Livermore, Calif.), Yifei Zhu (San Jose, Calif.), Bharathi Vennapusa (Tucson, Ariz.) and Patrick C. Roche (Tucson, Ariz.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides programmed death-ligand 1 (PD-L1) antibodies and methods of using the same."

The patent was filed on Nov. 21, 2022, under Application No. 18/057,465.

*For further information, including images, chart...